3 false false false false false false false false false true false false false false false false No description of principal activity 2022-07-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 10228348 2022-07-01 2023-06-30 10228348 2023-06-30 10228348 2021-07-01 2022-06-30 10228348 2022-06-30 10228348 bus:LeadAgentIfApplicable 2022-07-01 2023-06-30 10228348 bus:Director1 2022-07-01 2023-06-30 10228348 core:WithinOneYear 2023-06-30 10228348 core:WithinOneYear 2022-06-30 10228348 core:RestatedAmount 2022-06-30 10228348 bus:Micro-entities 2022-07-01 2023-06-30 10228348 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 10228348 bus:FullAccounts 2022-07-01 2023-06-30 10228348 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 10228348 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30
COMPANY REGISTRATION NUMBER: 10228348
Neuro London Limited
Filleted Unaudited Financial Statements
30 June 2023
Neuro London Limited
Financial Statements
Year ended 30 June 2023
Contents
Page
Chartered accountant's report to the director on the preparation of the unaudited statutory financial statements
1
Statement of financial position and the notes to the financial statements
2
Neuro London Limited
Chartered Accountant's Report to the Director on the Preparation of the Unaudited Statutory Financial Statements of Neuro London Limited
Year ended 30 June 2023
As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the year ended 30 June 2023, which comprise the statement of financial position and the notes to the financial statements. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
COOLEY & CO Chartered accountants
Sampuran House 3a Chislehurst Road Orpington Kent BR6 0DF
11 April 2024
Neuro London Limited
Statement of Financial Position
30 June 2023
2023
2022
£
£
Fixed assets
47,744
10,697
--------
--------
Current assets
85,841
152,881
Creditors: amounts falling due within one year
12,282
32,662
--------
---------
Net current assets
73,559
120,219
---------
---------
Total assets less current liabilities
121,303
130,916
Provisions for liabilities
9,071
2,032
Accruals and deferred income
-
1,600
---------
---------
112,232
127,284
---------
---------
Capital and reserves
112,232
127,284
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 3 (2022: 3 ).
2. Director's advances, credits and guarantees
The director operates a loan account with the company. At the year end the director owed £139 (2022:£Nil) to the company.
For the year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 11 April 2024 , and are signed on behalf of the board by:
N. Khan-Bourne
Director
Company registration number: 10228348
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Sampuran House, 3a, Chislehurst Road, Orpington, Kent, BR6 0DF, England.